2017_SBRT_Course Book
EGFR inhibitors in NSCLC
8 months later
3 months after WBRT (30 Gy):
Erlotinib 150 mg
60y, f, NSCLC IV, multiple BM
Fekrazad M H et al. JCO 2007;25:5024-5026
Made with FlippingBook Annual report
EGFR inhibitors in NSCLC
8 months later
3 months after WBRT (30 Gy):
Erlotinib 150 mg
60y, f, NSCLC IV, multiple BM
Fekrazad M H et al. JCO 2007;25:5024-5026
Made with FlippingBook Annual report